speb/financial-data huggingface dataset:
HRTG income_statement (quarterly, 2026-03-31) — Net Interest Income: -1779000.00
HRTG cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -42491000.00
HRTG cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -938000.00
HRTG cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -938000.00
HRTG income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1779000.00
HRTG cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -8909000.00
HRTG cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 17000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Net PPE: 46753000.00
HRTG cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1816000.00
HRTG income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 91597000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 491729000.00
HRTG income_statement (quarterly, 2026-03-31) — Normalized Income: 36483000.00
HRTG cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 24864000.00
HRTG income_statement (quarterly, 2026-03-31) — Operating Revenue: 227258000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 30334925.00
HRTG balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -13988000.00
HRTG income_statement (quarterly, 2026-03-31) — Other Gand A: 28508000.00
HRTG income_statement (quarterly, 2026-03-31) — Other Income Expense: 3083000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 28643000.00
HRTG cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -61000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Other Payable: 14368000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 107992000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Payables: 120651000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 120675000.00
HRTG income_statement (quarterly, 2026-03-31) — Policyholder Benefits Ceded: 3447000.00
HRTG income_statement (quarterly, 2026-03-31) — Policyholder Benefits Gross: 95044000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 194607000.00
HRTG income_statement (quarterly, 2026-03-31) — Pretax Income: 49039000.00
HRTG cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -77159000.00
HRTG cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1816000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Receivables: 355168000.00
HRTG income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3152000.00
HRTG cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -938000.00
HRTG cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -10006000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 319733000.00
HRTG cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 34668000.00
HRTG income_statement (quarterly, 2026-03-31) — Selling General And Administration: 28508000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Share Issued: 43043218.00
HRTG cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 986000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 520372000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 491729000.00
HRTG income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
HRTG income_statement (quarterly, 2026-03-31) — Tax Provision: 12556000.00
HRTG income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.26
HRTG balance_sheet (quarterly, 2026-03-31) — Total Assets: 2020984000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 524860000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Total Debt: 99048000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 520372000.00
HRTG income_statement (quarterly, 2026-03-31) — Total Expenses: 178219000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1500612000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 15499000.00
HRTG balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 12708293.00
HRTG balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 143189000.00
HRTX cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 478000.00
HRTX balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 2417000.00
HRTX balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 7996000.00
HRTX balance_sheet (annual, 2021-12-31) — Prepaid Assets: 12962000.00
HRTX income_statement (annual, 2022-12-31) — +Operating Expense: 227456000.00
HRTX income_statement (annual, 2022-12-31) — +Total Revenue: 107672000.00
HRTX balance_sheet (annual, 2022-12-31) — Accounts Payable: 3588000.00
HRTX balance_sheet (annual, 2022-12-31) — Accounts Receivable: 52049000.00
HRTX balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -14293000.00
HRTX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1807855000.00
HRTX cash_flow (annual, 2022-12-31) — Amortization Of Securities: -736000.00
HRTX cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 209000.00
HRTX income_statement (annual, 2022-12-31) — Basic Average Shares: 108996407.00
HRTX income_statement (annual, 2022-12-31) — Basic EPS: -1.67
HRTX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 90541000.00
HRTX cash_flow (annual, 2022-12-31) — Capital Expenditure: -1825000.00
HRTX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 8193000.00
HRTX balance_sheet (annual, 2022-12-31) — Capital Stock: 1191000.00
HRTX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 15364000.00
HRTX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 84852000.00
HRTX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 75059000.00
HRTX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -3324000.00
HRTX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -146912000.00
HRTX cash_flow (annual, 2022-12-31) — Change In Account Payable: -578000.00
HRTX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 11803000.00
HRTX cash_flow (annual, 2022-12-31) — Change In Inventory: -6191000.00
HRTX cash_flow (annual, 2022-12-31) — Change In Payable: -578000.00
HRTX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 11225000.00
HRTX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 1010000.00
HRTX cash_flow (annual, 2022-12-31) — Change In Receivables: -16550000.00
HRTX cash_flow (annual, 2022-12-31) — Change In Working Capital: -10506000.00
HRTX cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -16550000.00
HRTX cash_flow (annual, 2022-12-31) — Changes In Cash: -75177000.00
HRTX balance_sheet (annual, 2022-12-31) — Common Stock: 1191000.00
HRTX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 13572000.00
HRTX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 75145000.00
HRTX income_statement (annual, 2022-12-31) — Cost Of Revenue: 54874000.00
HRTX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 64791000.00
HRTX balance_sheet (annual, 2022-12-31) — Current Assets: 205435000.00
HRTX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 2694000.00
HRTX balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2694000.00
HRTX balance_sheet (annual, 2022-12-31) — Current Liabilities: 82355000.00
HRTX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 2889000.00
HRTX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2889000.00
HRTX income_statement (annual, 2022-12-31) — Diluted Average Shares: 108996407.00
HRTX income_statement (annual, 2022-12-31) — Diluted EPS: -1.67
HRTX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -182024000.00
HRTX income_statement (annual, 2022-12-31) — EBIT: -179550000.00
HRTX income_statement (annual, 2022-12-31) — EBITDA: -176661000.00
HRTX cash_flow (annual, 2022-12-31) — End Cash Position: 15364000.00
HRTX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 75059000.00
HRTX balance_sheet (annual, 2022-12-31) — Finished Goods: 18713000.00
HRTX cash_flow (annual, 2022-12-31) — Free Cash Flow: -148737000.00
HRTX cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 283000.00
HRTX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -19000.00
HRTX income_statement (annual, 2022-12-31) — General And Administrative Expense: 62239000.00
HRTX balance_sheet (annual, 2022-12-31) — Gross PPE: 44098000.00
HRTX income_statement (annual, 2022-12-31) — Gross Profit: 52798000.00
HRTX income_statement (annual, 2022-12-31) — Interest Expense: 2474000.00
HRTX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 2474000.00
HRTX income_statement (annual, 2022-12-31) — Interest Income: 1638000.00
HRTX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1638000.00
HRTX cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 2250000.00
HRTX balance_sheet (annual, 2022-12-31) — Interest Payable: 94000.00
HRTX balance_sheet (annual, 2022-12-31) — Inventory: 54573000.00
HRTX balance_sheet (annual, 2022-12-31) — Invested Capital: 162856000.00
HRTX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -3324000.00
HRTX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 75145000.00
HRTX cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
HRTX balance_sheet (annual, 2022-12-31) — Leases: 647000.00
HRTX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 5499000.00
HRTX balance_sheet (annual, 2022-12-31) — Long Term Debt: 149284000.00
HRTX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 154783000.00
HRTX cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
HRTX balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 2488000.00
HRTX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 75145000.00
HRTX balance_sheet (annual, 2022-12-31) — Net Debt: 133920000.00
HRTX income_statement (annual, 2022-12-31) — Net Income: -182024000.00
HRTX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -182024000.00
HRTX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -182024000.00
HRTX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -182024000.00
HRTX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -182024000.00
HRTX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -182024000.00
HRTX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -182024000.00
HRTX income_statement (annual, 2022-12-31) — Net Interest Income: -836000.00
HRTX cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1726000.00
HRTX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
HRTX cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
HRTX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -836000.00
HRTX balance_sheet (annual, 2022-12-31) — Net PPE: 29805000.00
HRTX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1598000.00
HRTX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 13572000.00
HRTX income_statement (annual, 2022-12-31) — Normalized EBITDA: -176661000.00
HRTX income_statement (annual, 2022-12-31) — Normalized Income: -182024000.00
HRTX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -146912000.00
HRTX cash_flow (annual, 2022-12-31) — Operating Gains Losses: 283000.00
HRTX income_statement (annual, 2022-12-31) — Operating Income: -174658000.00
HRTX income_statement (annual, 2022-12-31) — Operating Revenue: 107672000.00
HRTX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 119155000.00
HRTX balance_sheet (annual, 2022-12-31) — Other Current Assets: 13961000.00
HRTX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -19000.00
HRTX income_statement (annual, 2022-12-31) — Other Gand A: 62239000.00
HRTX income_statement (annual, 2022-12-31) — Other Income Expense: -6530000.00
HRTX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 202000.00
HRTX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 15711000.00
HRTX balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 241000.00
HRTX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -6530000.00
HRTX balance_sheet (annual, 2022-12-31) — Other Properties: 40963000.00
HRTX balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 69488000.00
HRTX balance_sheet (annual, 2022-12-31) — Payables: 3588000.00
HRTX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 68379000.00
HRTX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11282000.00
HRTX balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
HRTX income_statement (annual, 2022-12-31) — Pretax Income: -182024000.00
HRTX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: -86000.00
HRTX balance_sheet (annual, 2022-12-31) — Properties: 0.00
HRTX cash_flow (annual, 2022-12-31) — Purchase Of Investment: -145683000.00
HRTX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1825000.00
HRTX balance_sheet (annual, 2022-12-31) — Raw Materials: 15137000.00
HRTX balance_sheet (annual, 2022-12-31) — Receivables: 52049000.00
HRTX income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 54874000.00
HRTX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2889000.00
HRTX income_statement (annual, 2022-12-31) — Research And Development: 82704000.00
HRTX balance_sheet (annual, 2022-12-31) — Retained Earnings: -1795455000.00
HRTX cash_flow (annual, 2022-12-31) — Sale Of Investment: 143957000.00
HRTX cash_flow (annual, 2022-12-31) — Sale Of PPE: 227000.00
HRTX income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 82513000.00
HRTX income_statement (annual, 2022-12-31) — Selling General And Administration: 144752000.00
HRTX balance_sheet (annual, 2022-12-31) — Share Issued: 119155000.00
HRTX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 42980000.00
HRTX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 13572000.00
HRTX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 13572000.00
HRTX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
HRTX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
HRTX balance_sheet (annual, 2022-12-31) — Total Assets: 250951000.00
HRTX balance_sheet (annual, 2022-12-31) — Total Capitalization: 162856000.00
HRTX balance_sheet (annual, 2022-12-31) — Total Debt: 157477000.00
HRTX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 13572000.00
HRTX income_statement (annual, 2022-12-31) — Total Expenses: 282330000.00
HRTX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 237379000.00
HRTX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 45516000.00
HRTX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 155024000.00
HRTX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -174658000.00
HRTX balance_sheet (annual, 2022-12-31) — Work In Process: 20723000.00
HRTX balance_sheet (annual, 2022-12-31) — Working Capital: 123080000.00
HRTX income_statement (annual, 2023-12-31) — +Operating Expense: 172554000.00
HRTX income_statement (annual, 2023-12-31) — +Total Revenue: 127044000.00
HRTX balance_sheet (annual, 2023-12-31) — Accounts Payable: 3799000.00
HRTX balance_sheet (annual, 2023-12-31) — Accounts Receivable: 60137000.00
HRTX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -17028000.00
HRTX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1870525000.00
HRTX cash_flow (annual, 2023-12-31) — Amortization Of Securities: -1739000.00
HRTX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 617000.00
HRTX income_statement (annual, 2023-12-31) — Basic Average Shares: 138135000.00
HRTX income_statement (annual, 2023-12-31) — Basic EPS: -0.80
HRTX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 15364000.00
HRTX cash_flow (annual, 2023-12-31) — Capital Expenditure: -1545000.00
HRTX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 5875000.00
HRTX balance_sheet (annual, 2023-12-31) — Capital Stock: 1503000.00
HRTX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 28677000.00
HRTX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 80409000.00
HRTX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 54107000.00
HRTX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 17995000.00
HRTX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -58789000.00
HRTX cash_flow (annual, 2023-12-31) — Change In Account Payable: 15000.00
HRTX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -3026000.00
HRTX cash_flow (annual, 2023-12-31) — Change In Inventory: 12463000.00
HRTX cash_flow (annual, 2023-12-31) — Change In Payable: 15000.00
HRTX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -3011000.00
HRTX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 15426000.00
HRTX cash_flow (annual, 2023-12-31) — Change In Receivables: -8088000.00
HRTX cash_flow (annual, 2023-12-31) — Change In Working Capital: 16790000.00
HRTX cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -8088000.00
HRTX cash_flow (annual, 2023-12-31) — Changes In Cash: 13313000.00
HRTX balance_sheet (annual, 2023-12-31) — Common Stock: 1503000.00
HRTX balance_sheet (annual, 2023-12-31) — Common Stock Equity: -33973000.00
HRTX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 29755000.00
HRTX income_statement (annual, 2023-12-31) — Cost Of Revenue: 65105000.00
HRTX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 64958000.00
HRTX balance_sheet (annual, 2023-12-31) — Current Assets: 188774000.00
HRTX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 3075000.00
HRTX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 3075000.00
HRTX balance_sheet (annual, 2023-12-31) — Current Liabilities: 79685000.00
HRTX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2899000.00
HRTX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2899000.00
HRTX income_statement (annual, 2023-12-31) — Diluted Average Shares: 138135000.00
HRTX income_statement (annual, 2023-12-31) — Diluted EPS: -0.80
HRTX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -110559000.00
HRTX income_statement (annual, 2023-12-31) — EBIT: -106691000.00
HRTX income_statement (annual, 2023-12-31) — EBITDA: -103792000.00
HRTX cash_flow (annual, 2023-12-31) — End Cash Position: 28677000.00
HRTX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 54107000.00
HRTX balance_sheet (annual, 2023-12-31) — Finished Goods: 9917000.00
HRTX cash_flow (annual, 2023-12-31) — Free Cash Flow: -60334000.00
HRTX cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 627000.00
HRTX balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 13000.00
HRTX income_statement (annual, 2023-12-31) — General And Administrative Expense: 65778000.00
HRTX balance_sheet (annual, 2023-12-31) — Gross PPE: 42632000.00
HRTX income_statement (annual, 2023-12-31) — Gross Profit: 61939000.00
HRTX income_statement (annual, 2023-12-31) — Interest Expense: 3868000.00
HRTX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 3868000.00
HRTX income_statement (annual, 2023-12-31) — Interest Income: 3364000.00
HRTX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3364000.00
HRTX cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3059000.00
HRTX balance_sheet (annual, 2023-12-31) — Interest Payable: 412000.00
HRTX balance_sheet (annual, 2023-12-31) — Inventory: 42110000.00
HRTX balance_sheet (annual, 2023-12-31) — Invested Capital: 139780000.00
HRTX cash_flow (annual, 2023-12-31) — Investing Cash Flow: 17995000.00
HRTX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 29755000.00
HRTX cash_flow (annual, 2023-12-31) — Issuance Of Debt: 24350000.00
HRTX balance_sheet (annual, 2023-12-31) — Leases: 647000.00
HRTX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2800000.00
HRTX balance_sheet (annual, 2023-12-31) — Long Term Debt: 173753000.00
HRTX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 176553000.00
HRTX cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 24350000.00
HRTX cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
HRTX balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 2520000.00
HRTX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 29755000.00
HRTX balance_sheet (annual, 2023-12-31) — Net Debt: 145076000.00
HRTX income_statement (annual, 2023-12-31) — Net Income: -110559000.00
HRTX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -110559000.00
HRTX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -110559000.00
HRTX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -110559000.00
HRTX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -110559000.00
HRTX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -110559000.00
HRTX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -110559000.00
HRTX income_statement (annual, 2023-12-31) — Net Interest Income: -504000.00
HRTX cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 19527000.00
HRTX cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 24350000.00
HRTX cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 24350000.00
HRTX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -504000.00
HRTX balance_sheet (annual, 2023-12-31) — Net PPE: 25604000.00
HRTX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1532000.00
HRTX cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
HRTX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -33973000.00
HRTX income_statement (annual, 2023-12-31) — Normalized EBITDA: -103792000.00
HRTX income_statement (annual, 2023-12-31) — Normalized Income: -110559000.00
HRTX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -58789000.00
HRTX cash_flow (annual, 2023-12-31) — Operating Gains Losses: 627000.00
HRTX income_statement (annual, 2023-12-31) — Operating Income: -110615000.00
HRTX income_statement (annual, 2023-12-31) — Operating Revenue: 127044000.00
HRTX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 150285044.00
HRTX balance_sheet (annual, 2023-12-31) — Other Current Assets: 6118000.00
HRTX balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 13000.00
HRTX income_statement (annual, 2023-12-31) — Other Gand A: 65778000.00
HRTX income_statement (annual, 2023-12-31) — Other Income Expense: 560000.00
HRTX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 339000.00
HRTX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 8128000.00
HRTX balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 241000.00
HRTX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 560000.00
HRTX balance_sheet (annual, 2023-12-31) — Other Properties: 39465000.00
HRTX balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 51732000.00
HRTX balance_sheet (annual, 2023-12-31) — Payables: 3799000.00
HRTX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 68757000.00
HRTX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 7853000.00
HRTX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
HRTX cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
HRTX income_statement (annual, 2023-12-31) — Pretax Income: -110559000.00
HRTX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 2000.00
HRTX balance_sheet (annual, 2023-12-31) — Properties: 0.00
HRTX cash_flow (annual, 2023-12-31) — Purchase Of Investment: -87658000.00
HRTX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1545000.00
HRTX balance_sheet (annual, 2023-12-31) — Raw Materials: 17643000.00
HRTX balance_sheet (annual, 2023-12-31) — Receivables: 60137000.00
HRTX income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 65105000.00
HRTX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2899000.00
HRTX cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
HRTX income_statement (annual, 2023-12-31) — Research And Development: 39133000.00
HRTX balance_sheet (annual, 2023-12-31) — Retained Earnings: -1906014000.00
HRTX cash_flow (annual, 2023-12-31) — Sale Of Investment: 107185000.00
HRTX cash_flow (annual, 2023-12-31) — Sale Of PPE: 13000.00
HRTX income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 67643000.00
HRTX income_statement (annual, 2023-12-31) — Selling General And Administration: 133421000.00
HRTX balance_sheet (annual, 2023-12-31) — Share Issued: 150285044.00
HRTX income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
HRTX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 32854000.00
HRTX balance_sheet (annual, 2023-12-31) — Stockholders Equity: -33973000.00
HRTX balance_sheet (annual, 2023-12-31) — Tangible Book Value: -33973000.00
HRTX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
HRTX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
HRTX balance_sheet (annual, 2023-12-31) — Total Assets: 222506000.00
HRTX balance_sheet (annual, 2023-12-31) — Total Capitalization: 139780000.00
HRTX balance_sheet (annual, 2023-12-31) — Total Debt: 179628000.00
HRTX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -33973000.00
HRTX income_statement (annual, 2023-12-31) — Total Expenses: 237659000.00
HRTX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 256479000.00
HRTX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 33732000.00
HRTX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 176794000.00
HRTX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -110615000.00
HRTX income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
HRTX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
HRTX balance_sheet (annual, 2023-12-31) — Work In Process: 14550000.00
HRTX balance_sheet (annual, 2023-12-31) — Working Capital: 109089000.00
HRTX cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 828000.00
HRTX cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -431000.00
HRTX balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 3249000.00
HRTX cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: -3441000.00
HRTX balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 522000.00
HRTX cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 14000.00
HRTX income_statement (annual, 2024-12-31) — +Operating Expense: 117165000.00
HRTX income_statement (annual, 2024-12-31) — +Total Revenue: 144285000.00
HRTX balance_sheet (annual, 2024-12-31) — Accounts Payable: 11709000.00
HRTX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 78881000.00
HRTX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -17847000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -17847000.00
HRTX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1884409000.00
HRTX cash_flow (annual, 2024-12-31) — Amortization Of Securities: -2143000.00
HRTX income_statement (annual, 2024-12-31) — Basic Average Shares: 152449000.00
HRTX income_statement (annual, 2024-12-31) — Basic EPS: -0.09
HRTX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 28677000.00
HRTX cash_flow (annual, 2024-12-31) — Capital Expenditure: -1706000.00
HRTX cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -638000.00
HRTX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3037000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 3037000.00
HRTX balance_sheet (annual, 2024-12-31) — Capital Stock: 1521000.00
HRTX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 25802000.00
HRTX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 59283000.00
HRTX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 940000.00
HRTX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 18714000.00
HRTX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -22529000.00
HRTX cash_flow (annual, 2024-12-31) — Change In Account Payable: 8469000.00
HRTX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 3649000.00
HRTX cash_flow (annual, 2024-12-31) — Change In Inventory: -11050000.00
HRTX cash_flow (annual, 2024-12-31) — Change In Payable: 8469000.00
HRTX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 12118000.00
HRTX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -9927000.00
HRTX cash_flow (annual, 2024-12-31) — Change In Receivables: -18744000.00
HRTX cash_flow (annual, 2024-12-31) — Change In Working Capital: -27603000.00
HRTX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -18744000.00
HRTX cash_flow (annual, 2024-12-31) — Changes In Cash: -2875000.00
HRTX balance_sheet (annual, 2024-12-31) — Common Stock: 1521000.00
HRTX balance_sheet (annual, 2024-12-31) — Common Stock Equity: -33651000.00
HRTX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
HRTX cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
HRTX income_statement (annual, 2024-12-31) — Cost Of Revenue: 38648000.00
HRTX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 68748000.00
HRTX balance_sheet (annual, 2024-12-31) — Current Assets: 209014000.00
HRTX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 3037000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 3037000.00
HRTX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 3037000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 3037000.00
HRTX balance_sheet (annual, 2024-12-31) — Current Liabilities: 91457000.00
HRTX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 2492000.00
HRTX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 2492000.00
HRTX income_statement (annual, 2024-12-31) — Diluted Average Shares: 152449000.00
HRTX income_statement (annual, 2024-12-31) — Diluted EPS: -0.09
HRTX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -13580000.00
HRTX income_statement (annual, 2024-12-31) — EBIT: -7548000.00
HRTX income_statement (annual, 2024-12-31) — EBITDA: -5056000.00
HRTX cash_flow (annual, 2024-12-31) — End Cash Position: 25802000.00
HRTX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 940000.00
HRTX balance_sheet (annual, 2024-12-31) — Finished Goods: 6237000.00
HRTX cash_flow (annual, 2024-12-31) — Free Cash Flow: -24235000.00
HRTX cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 4382000.00
HRTX cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 4382000.00
HRTX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 13000.00
HRTX income_statement (annual, 2024-12-31) — General And Administrative Expense: 53397000.00
HRTX balance_sheet (annual, 2024-12-31) — Gross PPE: 35497000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Gross PPE: 35497000.00
HRTX income_statement (annual, 2024-12-31) — Gross Profit: 105637000.00
HRTX income_statement (annual, 2024-12-31) — Interest Expense: 6032000.00
HRTX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 6032000.00
HRTX income_statement (annual, 2024-12-31) — Interest Income: 3550000.00
HRTX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 3550000.00
HRTX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 4860000.00
HRTX balance_sheet (annual, 2024-12-31) — Interest Payable: 237000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Interest Payable: 237000.00
HRTX balance_sheet (annual, 2024-12-31) — Inventory: 53160000.00
HRTX balance_sheet (annual, 2024-12-31) — Invested Capital: 141075000.00
HRTX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 18714000.00
HRTX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
HRTX cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
HRTX cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
HRTX cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
HRTX balance_sheet (annual, 2024-12-31) — Leases: 307000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Leases: 307000.00
HRTX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
HRTX balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
HRTX balance_sheet (annual, 2024-12-31) — Long Term Debt: 174726000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 174726000.00
HRTX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 174726000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 174726000.00
HRTX cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
HRTX cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
HRTX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
HRTX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2061000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 2061000.00
HRTX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
HRTX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
HRTX balance_sheet (annual, 2024-12-31) — Net Debt: 148924000.00
HRTX income_statement (annual, 2024-12-31) — Net Income: -13580000.00
HRTX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -13580000.00
HRTX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -13580000.00
HRTX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -13580000.00
HRTX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -13580000.00
HRTX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -13580000.00
HRTX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -13580000.00
HRTX income_statement (annual, 2024-12-31) — Net Interest Income: -2482000.00
HRTX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 20393000.00
HRTX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
HRTX cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
HRTX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
HRTX cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
HRTX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -2482000.00
HRTX balance_sheet (annual, 2024-12-31) — Net PPE: 17650000.00
HRTX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1679000.00
HRTX cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
HRTX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -33651000.00
HRTX income_statement (annual, 2024-12-31) — Normalized EBITDA: -5056000.00
HRTX income_statement (annual, 2024-12-31) — Normalized Income: -13580000.00
HRTX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -22529000.00
HRTX cash_flow (annual, 2024-12-31) — Operating Gains Losses: 4382000.00
HRTX income_statement (annual, 2024-12-31) — Operating Income: -11528000.00
HRTX income_statement (annual, 2024-12-31) — Operating Revenue: 144285000.00
HRTX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 152127878.00
HRTX balance_sheet (annual, 2024-12-31) — Other Current Assets: 17690000.00
HRTX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 13000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 13000.00
HRTX income_statement (annual, 2024-12-31) — Other Gand A: 53397000.00
HRTX income_statement (annual, 2024-12-31) — Other Income Expense: 430000.00
HRTX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 961000.00
HRTX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 6483000.00
HRTX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 615000.00
HRTX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 430000.00
HRTX balance_sheet (annual, 2024-12-31) — Other Properties: 33129000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Other Properties: 33129000.00
HRTX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 33481000.00
HRTX balance_sheet (annual, 2024-12-31) — Payables: 11709000.00
HRTX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 80457000.00
HRTX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 7963000.00
HRTX balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 7963000.00
HRTX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
HRTX balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
HRTX cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
HRTX income_statement (annual, 2024-12-31) — Pretax Income: -13580000.00
HRTX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 940000.00
HRTX cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 423000.00
HRTX balance_sheet (annual, 2024-12-31) — Properties: 0.00
HRTX balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
HRTX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -103087000.00
HRTX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1706000.00
HRTX balance_sheet (annual, 2024-12-31) — Raw Materials: 19733000.00
HRTX balance_sheet (annual, 2024-12-31) — Receivables: 78881000.00
HRTX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 38648000.00
HRTX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2492000.00
HRTX cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
HRTX income_statement (annual, 2024-12-31) — Research And Development: 16683000.00
HRTX balance_sheet (annual, 2024-12-31) — Retained Earnings: -1919594000.00
HRTX cash_flow (annual, 2024-12-31) — Sale Of Investment: 123480000.00
HRTX cash_flow (annual, 2024-12-31) — Sale Of PPE: 27000.00
HRTX income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 47085000.00
HRTX income_statement (annual, 2024-12-31) — Selling General And Administration: 100482000.00
HRTX balance_sheet (annual, 2024-12-31) — Share Issued: 152127878.00
HRTX income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
HRTX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 12962000.00
HRTX balance_sheet (annual, 2024-12-31) — Stockholders Equity: -33651000.00
HRTX balance_sheet (annual, 2024-12-31) — Tangible Book Value: -33651000.00
HRTX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
HRTX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
HRTX balance_sheet (annual, 2024-12-31) — Total Assets: 233147000.00
HRTX balance_sheet (annual, 2024-12-31) — Total Capitalization: 141075000.00
HRTX balance_sheet (annual, 2024-12-31) — Total Debt: 177763000.00
HRTX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -33651000.00
HRTX income_statement (annual, 2024-12-31) — Total Expenses: 155813000.00
HRTX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 266798000.00
HRTX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 24133000.00
HRTX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 175341000.00
HRTX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -11528000.00
HRTX income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
HRTX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
HRTX balance_sheet (annual, 2024-12-31) — Work In Process: 27190000.00
HRTX balance_sheet (annual, 2024-12-31) — Working Capital: 117557000.00
HRTX income_statement (quarterly, 2025-03-31) — +Operating Expense: 27292000.00
HRTX income_statement (quarterly, 2025-03-31) — +Total Revenue: 38903000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 12333000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 78736000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1886981000.00
HRTX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -281000.00
HRTX cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
HRTX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 153490000.00
HRTX income_statement (quarterly, 2025-03-31) — Basic EPS: 0.02
HRTX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 25802000.00
HRTX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -109000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2290000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1524000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 19269000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 50679000.00
HRTX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 64000.00
HRTX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 2273000.00
HRTX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -8870000.00
HRTX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 624000.00
HRTX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -2856000.00
HRTX cash_flow (quarterly, 2025-03-31) — Change In Inventory: -3772000.00
HRTX cash_flow (quarterly, 2025-03-31) — Change In Payable: 624000.00
HRTX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -2232000.00
HRTX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -8604000.00
HRTX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 145000.00
HRTX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -14463000.00
HRTX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 145000.00
HRTX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -6533000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Common Stock: 1524000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -28453000.00
HRTX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 64000.00
HRTX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 8457000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 73934000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Current Assets: 212841000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 2290000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2290000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 88557000.00
HRTX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 551000.00
HRTX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 551000.00
HRTX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 196921000.00
HRTX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.01
HRTX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 2635000.00
HRTX income_statement (quarterly, 2025-03-31) — EBIT: 3154000.00
HRTX income_statement (quarterly, 2025-03-31) — EBITDA: 3705000.00
HRTX cash_flow (quarterly, 2025-03-31) — End Cash Position: 19269000.00
HRTX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 64000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Finished Goods: 8471000.00
HRTX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -8979000.00
HRTX cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -34000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1000.00
HRTX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 12702000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 16628000.00
HRTX income_statement (quarterly, 2025-03-31) — Gross Profit: 30446000.00
HRTX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 636000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Inventory: 56932000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 146513000.00
HRTX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 2273000.00
HRTX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 64000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 174966000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 174966000.00
HRTX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 64000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Net Debt: 155697000.00
HRTX income_statement (quarterly, 2025-03-31) — Net Income: 2635000.00
HRTX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 2635000.00
HRTX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 2635000.00
HRTX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2635000.00
HRTX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2635000.00
HRTX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 2635000.00
HRTX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 2635000.00
HRTX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 2340000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Net PPE: 16628000.00
HRTX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -67000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -28453000.00
HRTX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 3705000.00
HRTX income_statement (quarterly, 2025-03-31) — Normalized Income: 2635000.00
HRTX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -8870000.00
HRTX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -34000.00
HRTX income_statement (quarterly, 2025-03-31) — Operating Income: 3154000.00
HRTX income_statement (quarterly, 2025-03-31) — Operating Revenue: 38903000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 152427000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 26494000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 1000.00
HRTX income_statement (quarterly, 2025-03-31) — Other Gand A: 12702000.00
HRTX income_statement (quarterly, 2025-03-31) — Other Income Expense: -519000.00
HRTX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 211000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 6283000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 682000.00
HRTX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -519000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Other Properties: 16628000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 31410000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Payables: 12333000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 86267000.00
HRTX income_statement (quarterly, 2025-03-31) — Pretax Income: 2635000.00
HRTX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -22902000.00
HRTX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -109000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 19508000.00
HRTX balance_sheet (quarterly, 2025-03-31) — Receivables: 78736000.00